debate: best upfront approach for advanced stage hodgkin lymphoma? - a (brentuximab vedotin) vd
Published 5 years ago • 1.3K plays • Length 16:32Download video MP4
Download video MP3
Similar videos
-
17:28
debate: best upfront approach for advanced stage hodgkin lymphoma? - a (bloemycin) vd
-
11:21
debate: brentuximab vedotin as upfront therapy for advanced hodgkin lymphoma? - yes
-
15:04
debate: best second line therapy for relapsed hodgkin lymphoma - brentuximab alone/ chemo
-
15:57
initial therapy of advanced stage hodgkin lymphoma: when to use abvd, a(bv)vd, and beacopp
-
11:54
debate: recurrent hodgkin's lymphoma after asct in cr on brentuximab vedotin - maintenance
-
19:40
gemma timmons | us hegemony debate | opposition (2/6)
-
1:05:16
protecting the legitimacy of medical expertise: combating misinformation in medicine
-
1:13:14
the great aids debate
-
15:15
debate: best second-line approach to induce lymphoma remission prior to sct? - brentuximab
-
28:55
what does the future hold for advanced stage hodgkin's lymphoma?
-
15:00
debate: hodgkin lymphoma patient who remains pet at the end of chemotherapy - radiation therapy
-
18:55
how i manage advanced stage hodgkin lymphoma and what do i do at first relapse
-
10:46
debate: value to using brentuximab vedotin consolidation early after auto-sct in hodgkin's? - yes
-
13:41
debate: best upfront therapy for advanced follicular lymphoma - obinutuzumab-based therapy
-
8:40
debate: value to using brentuximab vedotin consolidation early after auto-sct in hodgkin's? - no
-
27:49
hodgkin disease: the past, the present, and the future
-
12:18
debate: recurrent hodgkin's lymphoma after asct in cr on brentuximab vedotin - allotransplant
-
0:57
advantages of brentuximab vedotin and chemotherapy combination for advanced stage hodgkin lymphoma
-
14:34
debate: best pre-transplant second line therapy for relapsed hodgkin lymphoma - chemo alone
-
12:11
debate: hodgkin lymphoma patient who relapses after autologous sct - serial novel agents
-
18:13
how can we make hodgkin's disease therapy less toxic and more effective?
-
12:51
brentuximab vedotin plus avd: limiting toxicity in limited-stage hodgkin lymphoma